Abstract
The project here described aims to synthesize mesoporous silica nanoparticles to encapsulate doxorubicin for further functionalization with monoclonal antibodies for treating Hodgkin and anaplastic large cell CD-30+ lymphomas. As monoclonal antibodies exhibit highly specific binding sites, the aim of this work is to obtain a more effective chemotherapy for this type of lymphoma. In additi…